Pentair plc (NYSE:PNR) Q3 2025 Earnings Call October 21, 2025 9:00 AM EDT
Company Participants
Shelly Hubbard – Vice President of Investor Relations
John Stauch – President, CEO & Director
Robert Fishman – Executive VP & CFO
Conference Call Participants
C. Stephen Tusa – JPMorgan Chase & Co, Research Division
Andrew Kaplowitz – Citigroup Inc. Exchange Research
Deane Dray – RBC Capital Markets, Research Division
Damian Karas – UBS Investment Bank, Research Division
Michael Halloran – Robert W. Baird & Co. Incorporated, Research Division
Julian Mitchell – Barclays Bank PLC, Research Division
Bryan Blair – Oppenheimer & Co. Inc., Research Division
Nathan Jones – Stifel, Nicolaus & Company, Incorporated, Research Division
Nicklaus Cash – Goldman Sachs Group, Inc., Research Division
Andrew Buscaglia – BNP Paribas Exane, Research Division
Andrew Krill – Deutsche Bank AG, Research Division
Nigel Coe – Wolfe Research, LLC
Joseph Giordano – TD Cowen, Research Division
Jeffrey Hammond – KeyBanc Capital Markets Inc., Research Division
Scott Graham – Seaport Research Partners
Presentation
Operator
Welcome to the Pentair Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please also note today’s event is being recorded. At this time, I would like to turn the floor over to Shelly Hubbard, Vice President of Investor Relations. Please go ahead.
Shelly Hubbard
Vice President of Investor Relations
Thank you, operator, and welcome to Pentair’s Third Quarter 2025 Earnings Conference Call. On the call with me are John Stauch, our President and Chief Executive Officer; and Bob Fishman, our Chief Financial Officer. On today’s call, we will provide details on our third quarter performance as outlined in this morning’s press release. On the Pentair Investor Relations website, you can find our earnings release and slide deck, which is intended to supplement our prepared remarks during today’s call and provide a reconciliation of differences between GAAP and non-GAAP financial measures that we will reference. The non-GAAP financial measures provided should not be considered as a substitute for or superior to
Read the full article here